An arabinogalactan from fruits of Lycium barbarum L. inhibits production and aggregation of Aβ42
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 195, 643-651
Abstract
No abstract availableKeywords
Funding Information
- Key Basic Study on Function and Bioactivity of Lycium barbarum L
- Ningxia and Chinese Academy of Sciences, New Drug Creation and Manufacturing Program (2017ZX09305-003)
- National Natural Science Foundation of China (31500651, 31230022)
- Ministry of Science and Technology
- People Republic of China, Program of Shanghai Subject Chief Scientist (16XD1404500)
This publication has 36 references indexed in Scilit:
- Soluble Aβ oligomer production and toxicityJournal of Neurochemistry, 2011
- Amyloid Precursor Protein Processing and Alzheimer's DiseaseAnnual Review of Neuroscience, 2011
- Cell wall polysaccharides of Chinese Wolfberry (Lycium barbarum): Part 2. Characterisation of arabinogalactan-proteinsCarbohydrate Polymers, 2011
- Elucidation of the structure of a bioactive hydrophilic polysaccharide from Cordyceps sinensis by methylation analysis and NMR spectroscopyCarbohydrate Polymers, 2011
- The secretases: enzymes with therapeutic potential in Alzheimer diseaseNature Reviews Neurology, 2010
- Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on β-amyloid peptide neurotoxicityBrain Research, 2007
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Physiological roles for amyloid β peptidesThe Journal of Physiology, 2006
- Structure of a Hydroxyproline (Hyp)-Arabinogalactan Polysaccharide from Repetitive Ala-Hyp Expressed in Transgenic Nicotiana tabacumJournal of Biological Chemistry, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002